Inmune Bio Stock Forecast - Simple Exponential Smoothing

INMB
 Stock
  

USD 6.91  0.79  10.26%   

Inmune Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Inmune Bio historical stock prices and determine the direction of Inmune Bio's future trends based on various well-known forecasting models. However, solely looking at the historical price movement is usually misleading. Macroaxis recommends to always use this module together with analysis of Inmune Bio historical fundamentals such as revenue growth or operating cash flow patterns.
Please see Historical Fundamental Analysis of Inmune Bio to cross-verify your projections.
  

Open Interest Agains t 2022-10-21 Inmune Option Contracts

Although open interest is a measure utilized in the options markets, it could be used to forecast Inmune Bio's spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest Inmune Bio's options reflect these daily shifts, investors could use the patterns of these changes to develop long and short trading strategies Inmune Bio stock based on available contracts left at the end of a trading day.
Please note, to derive more accurate forecasting about market movement from the current Inmune Bio's open interest, investors have to compare it to Inmune Bio's spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Inmune Bio is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Inmune. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Most investors in Inmune Bio cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Inmune Bio's time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Inmune Bio's price structures and extracts relationships that further increase the generated results' accuracy.
Inmune Bio simple exponential smoothing forecast is a very popular model used to produce a smoothed price series. Whereas in simple Moving Average models the past observations for Inmune Bio are weighted equally, Exponential Smoothing assigns exponentially decreasing weights as Inmune Bio prices get older.

Inmune Bio Simple Exponential Smoothing Price Forecast For the 26th of September

Given 90 days horizon, the Simple Exponential Smoothing forecasted value of Inmune Bio on the next trading day is expected to be 6.91 with a mean absolute deviation of 0.26, mean absolute percentage error of 0.11, and the sum of the absolute errors of 15.37.
Please note that although there have been many attempts to predict Inmune Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Inmune Bio's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Inmune Bio Stock Forecast Pattern

Backtest Inmune BioInmune Bio Price PredictionBuy or Sell Advice 

Inmune Bio Forecasted Value

In the context of forecasting Inmune Bio's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Inmune Bio's downside and upside margins for the forecasting period are 3.09 and 10.73, respectively. We have considered Inmune Bio's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value 6.91
6.91
Expected Value
10.73
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Simple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Inmune Bio stock data series using in forecasting. Note that when a statistical model is used to represent Inmune Bio stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria114.061
BiasArithmetic mean of the errors 0.0322
MADMean absolute deviation0.2562
MAPEMean absolute percentage error0.0287
SAESum of the absolute errors15.37
This simple exponential smoothing model begins by setting Inmune Bio forecast for the second period equal to the observation of the first period. In other words, recent Inmune Bio observations are given relatively more weight in forecasting than the older observations.

Predictive Modules for Inmune Bio

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Inmune Bio. Regardless of method or technology, however, to accurately forecast the stock or bond market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Inmune Bio's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Inmune Bio in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
3.016.8310.65
Details
Intrinsic
Valuation
LowReal ValueHigh
6.2214.1217.94
Details
2 Analysts
Consensus
LowTarget PriceHigh
32.0037.0042.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Inmune Bio. Your research has to be compared to or analyzed against Inmune Bio's peers to derive any actionable benefits. When done correctly, Inmune Bio's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Inmune Bio.

Other Forecasting Options for Inmune Bio

For every potential investor in Inmune, whether a beginner or expert, Inmune Bio's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Inmune Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Inmune. Basic forecasting techniques help filter out the noise by identifying Inmune Bio's price trends.

Inmune Bio Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Inmune Bio stock to make a market-neutral strategy. Peer analysis of Inmune Bio could also be used in its relative valuation, which is a method of valuing Inmune Bio by comparing valuation metrics with similar companies.
Croda Intl PlcSika FinanzSociedad Quimica YNOVOZYMES ASRPM InternationalVulcan Intl CpNippon Paint HoldingsAmn Healthcare ServicesTwist Bioscience CorpFreedom Holding CorpGx Nasdaq-100 CoveredFranklin Mutual EuropeanNatural Hlth TrdUSA Value FactorBetapro Canadian Gold
 Risk & Return  Correlation

Inmune Bio Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Inmune Bio's price movements, , a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Inmune Bio's current price.

Inmune Bio Market Strength Events

Market strength indicators help investors to evaluate how Inmune Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Inmune Bio shares will generate the highest return on investment. By undertsting and applying Inmune Bio stock market strength indicators, traders can identify Inmune Bio entry and exit signals to maximize returns.

Inmune Bio Risk Indicators

The analysis of Inmune Bio's basic risk indicators is one of the essential steps in helping accuretelly forecast its future price. The process involves identifying the amount of risk involved in Inmune Bio's investment and either accepting that risk or mitigating it. Along with some funamental techniques of forecasting Inmune Bio stock price, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stock investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Inmune Bio in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Inmune Bio's short interest history, or implied volatility extrapolated from Inmune Bio options trading.

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Inmune Bio using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see Historical Fundamental Analysis of Inmune Bio to cross-verify your projections. You can also try CEO Directory module to screen CEOs from public companies around the world.

Complementary Tools for analysis

When running Inmune Bio price analysis, check to measure Inmune Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inmune Bio is operating at the current time. Most of Inmune Bio's value examination focuses on studying past and present price action to predict the probability of Inmune Bio's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Inmune Bio's price. Additionally, you may evaluate how the addition of Inmune Bio to your portfolios can decrease your overall portfolio volatility.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Is Inmune Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inmune Bio. If investors know Inmune will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inmune Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Inmune Bio is measured differently than its book value, which is the value of Inmune that is recorded on the company's balance sheet. Investors also form their own opinion of Inmune Bio's value that differs from its market value or its book value, called intrinsic value, which is Inmune Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inmune Bio's market value can be influenced by many factors that don't directly affect Inmune Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inmune Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine Inmune Bio value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inmune Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.